Newsletter | November 25, 2025

11.25.25 -- Global Implications Of Zero Tariffs On Indian Pharma Exports To China

SPONSOR

Clinical trials drive medical progress, and SCOPE brings the community together to advance them. Returning February 2–5, 2026, in Orlando, SCOPE builds on 2025’s record 4,500+ attendees, 630 speakers, and 300 exhibitors. The 2026 program features 30 tracks, new additions in Market Access, Safety, and Therapeutic Areas, major awards, and expanded coverage of AI, patient-centric design, site engagement, and trial operations. SCOPE unites global leaders shaping the future of clinical research. www.SCOPEsummit.com

FEATURED EDITORIAL

Global Implications Of Zero Tariffs On Indian Pharma Exports To China

Discover the worldwide impacts of China’s zero-tariff policy on Indian pharmaceutical drugs.

INDUSTRY INSIGHTS

Study, Not Software: Aligning RTSM To The Protocol

RTSM systems are essential for immediate, real-time clinical trial decisions. Learn how to accommodate protocol changes and prioritizes user workflows with effective design flexibility. 

IRT: A New Approach To Meeting The Needs Of Early Phase Trials

As early phase clinical trials become more sophisticated, sponsors are now leveraging flexible IRT solutions to replace error-prone manual processes and gain greater control and efficiency.

SPONSOR

Spotlight the Best in CRO Partnerships—Share Your Voice!

Help shape the future of CRO excellence! Take part in the 2025 CRO Leadership Awards Survey, conducted by Tufts CSDD and Clinical Leader. Your confidential feedback will determine the top CROs in project management, services, culture, and more. Winners will be celebrated through Clinical Leader events—don’t miss your chance to spotlight outstanding collaboration in our industry!